Navigation Links
Lexicon Initiates Phase 2 Clinical Trial of LX2931 in Patients With Rheumatoid Arthritis
Date:8/4/2009

THE WOODLANDS, Texas, Aug. 4 /PRNewswire-FirstCall/ -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), a biopharmaceutical company focused on discovering and developing breakthrough treatments for human disease, announced today that it has initiated a Phase 2 clinical trial of LX2931 in patients with rheumatoid arthritis. LX2931 is an orally-delivered, small molecule drug candidate that has recently completed Phase 1 testing in normal volunteers. Lexicon also successfully completed a drug-drug interaction (DDI) study of LX2931 with methotrexate in patients with rheumatoid arthritis, with no clinically significant drug-drug interactions observed.

"We believe that, as an oral therapy, LX2931 could have advantages over current biologic therapies in treating patients with rheumatoid arthritis," said Philip M. Brown, M.D., J.D., senior vice president of clinical development at Lexicon. "LX2931 has demonstrated potent anti-inflammatory activity in preclinical models of arthritis and inflammation and, importantly, has been well tolerated in combination with methotrexate, the current standard of care first-line therapy."

LX2931 inhibits sphingosine-1-phosphate (S1P) lyase, an enzyme identified by Lexicon scientists as a promising new target on a pathway associated with regulation of the human immune system. Lexicon has previously shown that genetically "knocking out" or "knocking down" S1P lyase in mice substantially decr
'/>"/>

SOURCE Lexicon Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine news :

1. Lexicon Pharmaceuticals Provides Clinical Pipeline Update and Reports 2009 Second Quarter Financial Results
2. Tyco International Increases Quarterly Dividend 36 Percent to 15 Cents per Share; Initiates New $1 Billion Share Repurchase Program
3. Chemical Diversity Initiates International Prostrate Cancer Discovery Partnership
4. Vista Partners Initiates Coverage on Raptor Pharmaceuticals Corp.
5. GenPrime Initiates External Clinical Trials of its Bacterial Contamination Test for Rapid Detection of Bacteria in Platelets
6. U.S. Oncology Initiates Complete Phase Ib Trial of Brostallicin Combination Therapy in Advanced Solid Tumors
7. Harbinger Research Initiates Coverage on HearAtLast
8. Wyeth Consumer Healthcare Initiates Voluntary Recall and Replacement Program for Several Robitussin Products and Childrens Dimetapp Cold & Chest Congestion
9. MAP Pharmaceuticals Initiates Phase 2a Clinical Trial of Combination Therapy in Adult Patients with Asthma
10. Amira Pharmaceuticals Announces Favorable Phase 1 Clinical Trial Results for Lead Product Candidate AM103 and Initiates Clinical Studies for the 2nd Entry Molecule for the Treatment of Respiratory and Cardiovascular Disease
11. Arete Therapeutics Initiates Phase 1 Clinical Trial For AR9281 as a First-in-Class Antihypertensive Agent
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2013)... (PRWEB) May 24, 2013 This report ... provides an overview of the risk factors and global ... (US, France, Germany, Italy, Spain, UK, Australia, and Brazil). ... of meningococcal disease segmented by age (<1, 1–4, 5–14, ... C, Y, and W-135) in these markets. The other ...
(Date:5/24/2013)... Child safety expert and author, Irene ... gifts for teachers that can "show appreciation for the ... der Zande is the founder of Kidpower, a leading ... mission is to help people create cultures of ... an incredible impact on the emotional and physical safety ...
(Date:5/24/2013)... May 24, 2013 May is National ... that weakens the bones resulting in an increased risk ... , explains “Today osteoporosis affects more than 10 million ... density, placing them at increased risk for the disease. ... one in every five diagnosed with osteoporosis is a ...
(Date:5/24/2013)... 24, 2013 Chronic Fatigue Syndrome has ... sufferers with unexplained fatigue lasting 6 months or longer. ... memory and concentration impairment, muscle and joint pain without ... un-refreshing sleep and malaise that lasts for more than ... known to be linked to insulin resistance. At a ...
(Date:5/24/2013)... British Menopause Society and Women,s Health Concern have today ... provide clarity around the role of HRT, the benefits ... society,s flagship title, Menopause International , published by ... has changed from being branded the "elixir of youth" ... used in certain circumstances. Since the publication of the ...
Breaking Medicine News(10 mins):Health News:Meningococcal Disease Market Analysis and 2022 Forecasts in New Research Report at RnRMarketResearch.com 2Health News:Meningococcal Disease Market Analysis and 2022 Forecasts in New Research Report at RnRMarketResearch.com 3Health News:Meningococcal Disease Market Analysis and 2022 Forecasts in New Research Report at RnRMarketResearch.com 4Health News:Kidpower's 7 Tips For Parents To Find Meaningful End-Of-Year Gifts for Your Child’s Teacher 2Health News:Kidpower's 7 Tips For Parents To Find Meaningful End-Of-Year Gifts for Your Child’s Teacher 3Health News:Kidpower's 7 Tips For Parents To Find Meaningful End-Of-Year Gifts for Your Child’s Teacher 4Health News:Simple Ways to Protect Yourself from the Risks of Osteoporosis 2Health News:hCGTreatments / Diet Doc hCG Diets & Weight Loss Plans Announces New hCG Diet Plans to Promote Fast Weight Loss Shown to Reduce the Risk & Symptoms of Chronic Fatigue 2Health News:hCGTreatments / Diet Doc hCG Diets & Weight Loss Plans Announces New hCG Diet Plans to Promote Fast Weight Loss Shown to Reduce the Risk & Symptoms of Chronic Fatigue 3
... ... begun the new year by expanding their existing Green Bay, WI presence with the ... ... growing technology company representing both businesses and residents has joined forces with Buildmyownsite, Inc., ...
... ... them on a road to schizophrenia may be protected against some forms of cancer, according to ... ... inherit a specific form of a gene that puts them on a road to schizophrenia may ...
... emergency department, federal report shows , THURSDAY, Jan. 14 ... million motor vehicle crash victims who had injuries ranging ... a new government study finds. , About 85 percent ... 321,000 were admitted or transferred to another acute care ...
... but doing it takes reporter from the brink of ... to roll your eyes when a doctor prescribes diet and exercise as ... for me. , In the past year, I used diet and ... my cholesterol. I did it armed with knowledge given to me by ...
... , WASHINGTON , Jan. 15 ... small amount of cognitive training can cut the crash risk of older drivers ... meeting of the Transportation Research Board of the National Academy of Sciences. ... join the ranks of some 39 million drivers already over age 65. Over ...
... ... concern of hospitals is keeping their patients safe while within their facility. To ... identifiers to patients that may present a higher risk of falling while in ... for a variety of reasons, have a higher than normal risk of being ...
Cached Medicine News:Health News:Infinity Technology, Inc. Acquires Build My Own Site, Inc. 2Health News:Gene Linked to Schizophrenia May Reduce Cancer Risk 2Health News:From Risky Health Status to a Better Life 2Health News:From Risky Health Status to a Better Life 3Health News:From Risky Health Status to a Better Life 4Health News:From Risky Health Status to a Better Life 5Health News:Brain Fitness Predicts Crash Risk 2Health News:Brain Fitness Predicts Crash Risk 3Health News:Brain Fitness Predicts Crash Risk 4Health News:Midbrook Assists Local Hospital with Fall Kit Production 2Health News:Midbrook Assists Local Hospital with Fall Kit Production 3
(Date:5/23/2013)... 2013 3SBio Inc. (NASDAQ: ... China -based biotechnology company focused ... announced today that, at an extraordinary general meeting ... in favor of the proposal to authorize and ... merger dated February 8, 2013, among Decade Sunshine ...
(Date:5/23/2013)... SAN DIEGO , May 23, 2013 Neurocrine ... Kevin Gorman , President and Chief Executive ... Bank 38 th Annual dbAccess Health Care Conference in ... Thursday, May 30 at 11:20 a.m. Eastern Time / 8:20 ... be accessed on the Company,s website at http://www.neurocrine.com . ...
(Date:5/23/2013)... May 23, 2013 Nephros, Inc. (OTC Bulletin ... device company that develops and sells high performance liquid ... rights offering.  In addition, the concurrent temporary reduction in ... on May 17, 2013. Nephros estimates that ... the rights offering.   A portion of the proceeds will ...
Breaking Medicine Technology:3SBio Inc. Announces Shareholders' Approval of the Amended Merger Agreement 23SBio Inc. Announces Shareholders' Approval of the Amended Merger Agreement 3Nephros Announces Completion of Rights Offering 2Nephros Announces Completion of Rights Offering 3Nephros Announces Completion of Rights Offering 4
... Amgen (Nasdaq: AMGN ) will participate in the ... St. Regis New York in New York City, beginning at ... of Global Development, for Amgen, will present at the conference. ... Internet and can be accessed from Amgen,s website, www.amgen.com ...
... Transgenomic, Inc. (OTC Bulletin Board: ... for CE IVD labeling and has significantly expanded distribution ... most of the European Union. The SURVEYOR Scan K-RAS ... of mutation detection kits, which features proprietary SURVEYOR endonuclease ...
Cached Medicine Technology:Transgenomic Expands Distribution of SURVEYOR® Scan K-RAS Mutation Detection Kit With CE IVD Mark 2Transgenomic Expands Distribution of SURVEYOR® Scan K-RAS Mutation Detection Kit With CE IVD Mark 3Transgenomic Expands Distribution of SURVEYOR® Scan K-RAS Mutation Detection Kit With CE IVD Mark 4Transgenomic Expands Distribution of SURVEYOR® Scan K-RAS Mutation Detection Kit With CE IVD Mark 5
... Used for stone manipulation and ... Enhanced wire strength permits the ... more readily than standard flat-wire ... easy, ergonomic one-handed operation. Supplied ...
... manipulation and removal in the urinary tract. The ... its shape following extreme torsion. The unique tipless ... the basket to open at the base of ... design reduces the likelihood of mucosal damage and ...
Used to establish and maintain nephrostomy drainage following pyeloplasty. Supplied sterile in peel-open packages. Intended for one-time use. CAUTION: Periodic evaluation is advised; stent must not r...
... Analyzer is an in vitro diagnostic ... chemistry parameters using Reflotron Test Tabs. It works ... rapid and reliable results while being easy to ... display and the profile can be printed out ...
Medicine Products: